Acquisition Avalon Capital Invest 
socalTECH
JULY 16, 2013
In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. The fund has not yet announced local investments, but has been actively talking to companies fitting its investment profile. READ MORE>>.
Xconomy
SEPTEMBER 11, 2019
GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.
Expert insights. Personalized for you.
174 
Let's personalize your content